We are sharing a specialised part-time consulting opportunity for experienced biotech investment professionals with deep expertise in evaluating pharmaceutical assets, clinical-stage drug-development programmes, company fundamentals, and investment opportunities within the US biotech and healthcare market.
This role supports an expert evaluation initiative focused on commercial drugs and drug-development programmes. Selected professionals will develop and critique structured evaluation rubrics, assess individual drug assets and the companies behind them, and apply specialist investment judgement across a focused set of biotech companies.
Key Responsibilities
Drug Asset Assessment
- Evaluate commercial and clinical-stage drug assets across different therapeutic areas
- Assess mechanism of action, biological rationale, clinical data, development progress, and regulatory considerations
- Analyse competitive positioning within relevant therapeutic and treatment landscapes
- Identify key scientific, clinical, regulatory, and commercial value drivers
- Flag unsupported assumptions, evidence gaps, or material risks within asset assessments
Company & Investment Analysis
- Conduct end-to-end assessments of biotech and pharmaceutical companies
- Evaluate pipeline quality, company strategy, competitive differentiation, and major catalysts
- Assess the relationship between individual drug assets and overall company valuation
- Review investment-style theses for analytical strength, supporting evidence, and internal consistency
- Identify weak, overly confident, or missing assumptions within investment conclusions
- Apply consistent investment judgement across approximately 5–10 companies during the pilot
Clinical & Commercial Evaluation
- Interpret clinical trial results and assess the strength and relevance of available evidence
- Evaluate potential differentiation against existing and emerging standards of care
- Analyse addressable markets, competitive dynamics, development timelines, and commercial opportunity
- Assess how clinical, regulatory, and market developments may affect asset and company value
- Distinguish between well-supported conclusions and speculative investment assumptions
Rubric Development & Expert Review
- Create structured evaluation rubrics for biotech companies and drug-development programmes
- Critique existing rubrics for completeness, realism, and investment relevance
- Define criteria reflecting experienced biotech investment judgement
- Identify missing considerations or weak assumptions in analytical frameworks
- Provide clear written reasoning supporting evaluation decisions
Ideal Profile
- 5+ years of experience evaluating biotech, pharmaceutical, or healthcare companies or assets
- Professional experience as a biotech or healthcare investment analyst, ideally within a specialist investment fund
- Strong familiarity with biotech and pharmaceutical drug-development programmes
- Experience assessing drug assets from scientific, clinical, commercial, and investment perspectives
- Strong understanding of clinical data, mechanisms of action, competitive landscapes, and biotech valuation drivers
- Ability to evaluate both individual assets and the broader companies developing them
- Experience developing, reviewing, or presenting investment theses
- Strong analytical judgement and ability to identify unsupported or incomplete assumptions
- US-based or possessing deep professional experience covering the US biotech and healthcare investment market
- Availability for approximately 10–20 hours over an initial 1–2 week pilot
Engagement Details
- Part-time independent contractor engagement
- Approximately 10–20 hours over an initial 1–2 week pilot
- Fully remote with flexible scheduling
- Compensation of $125–$185/hour
- Potential for recurring project work for strong contributors
- Work must be completed without using confidential or proprietary information belonging to any employer, client, fund, institution, or other third party
- H1-B and STEM OPT support is unavailable for this engagement
About the Platform
This opportunity is available through 24-MAG LLC. We connect experienced professionals with remote consulting opportunities across technical, evaluation, and project-based workstreams.
By submitting this application, you acknowledge that your information may be processed by 24-MAG LLC for recruitment and opportunity matching in accordance with our Privacy Policy: https://www.24-mag.com/privacy-policy.
